Inactive Instrument
Transcripts Celsion Corporation Nasdaq
Stocks
US15117N4043
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-26 | IMUNON Hosts 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial And Clinical Potential Of IMNN-001 | CI |
| 08-11 | Imunon, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















